Silvercrest Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-24,539
| Closed | -$346K | – | 941 |
|
|
2024
Q1 | $346K | Hold |
24,539
| – | – | ﹤0.01% | 780 |
|
|
2023
Q4 | $256K | Buy |
24,539
+11,449
| +87% | +$120K | ﹤0.01% | 766 |
|
|
2023
Q3 | $134K | Buy |
+13,090
| New | +$134K | ﹤0.01% | 804 |
|
|
2016
Q4 | – | Sell |
-11,069
| Closed | -$509K | – | 584 |
|
|
2016
Q3 | $509K | Buy |
11,069
+621
| +6% | +$28.6K | 0.01% | 406 |
|
|
2016
Q2 | $525K | Sell |
10,448
-171
| -2% | -$8.59K | 0.01% | 400 |
|
|
2016
Q1 | $568K | Sell |
10,619
-30,000
| -74% | -$1.6M | 0.01% | 394 |
|
|
2015
Q4 | $2.67M | Buy |
40,619
+900
| +2% | +$59.1K | 0.04% | 267 |
|
|
2015
Q3 | $2.24M | Hold |
39,719
| – | – | 0.03% | 259 |
|
|
2015
Q2 | $2.35M | Sell |
39,719
-224
| -0.6% | -$13.2K | 0.03% | 281 |
|
|
2015
Q1 | $2.49M | Sell |
39,943
-49
| -0.1% | -$3.05K | 0.04% | 248 |
|
|
2014
Q4 | $2.3M | Buy |
39,992
+59
| +0.1% | +$3.39K | 0.03% | 261 |
|
|
2014
Q3 | $2.15M | Sell |
39,933
-449
| -1% | -$24.1K | 0.03% | 263 |
|
|
2014
Q2 | $2.12M | Buy |
40,382
+1
| +0% | +$52 | 0.03% | 265 |
|
|
2014
Q1 | $2.13M | Buy |
40,381
+1
| +0% | +$53 | 0.03% | 258 |
|
|
2013
Q4 | $1.62M | Sell |
40,380
-499
| -1% | -$20K | 0.03% | 279 |
|
|
2013
Q3 | $1.54M | Buy |
40,879
+1
| +0% | +$38 | 0.03% | 274 |
|
|
2013
Q2 | $1.6M | Buy |
+40,878
| New | +$1.6M | 0.03% | 264 |
|